These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3313883)

  • 1. Application of prostacyclin analogue and thromboxane synthetase inhibitor to chronic vascular rejection after kidney transplantation.
    Teraoka S; Takahashi K; Toma H; Sanaka T; Yamaguchi Y; Tanabe K; Sato H; Kawaguchi H; Oba S; Nakajima I
    Transplant Proc; 1987 Oct; 19(5):3664-8. PubMed ID: 3313883
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic effect of antiplatelet agents on obstructive vascular lesions after kidney transplantation with cyclosporine.
    Teraoka S; Oba S; Takahashi K; Yagisawa T; Yamaguchi Y; Sanaka T; Tanabe K; Kawai T; Fuchinoue S; Honda H
    Transplant Proc; 1987 Aug; 19(4 Suppl 5):77-81. PubMed ID: 3303573
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor.
    Teraoka S; Takahashi K; Toma H; Ota K
    Transplant Proc; 1993 Apr; 25(2):2085-6. PubMed ID: 8470279
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M
    Kokyu To Junkan; 1984 Sep; 32(9):955-61. PubMed ID: 6393261
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of combined administration of low dose cyclosporine A with a thromboxane synthetase inhibitor on acute cardiac allograft rejection.
    Sakurai Y; Kagawa K; Kato Y; Otani H; Nonoyama A
    Transplant Proc; 1990 Aug; 22(4):1686-8. PubMed ID: 2389433
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T; Nomura T; Ozawa Y; Maeda K; Shibata M
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor].
    Katoh K; Kani H; Imai T
    Masui; 1985 Jul; 34(7):966-72. PubMed ID: 4057547
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protective effect of a thromboxane synthetase inhibitor, OKY-046, in patients with acute respiratory failure].
    Sakio H; Usui Y; Mita H; Onoda N; Iida M; Okuda C
    Masui; 1984 Sep; 33(9):964-9. PubMed ID: 6542601
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective thromboxane synthetase inhibitor and ischemic heart disease.
    Ito T; Ogawa K; Watanabe J; Chen LS; Shikano M; Imaizumi M; Shibata T; Ito Y; Miyazaki Y; Satake T
    Biomed Biochim Acta; 1984; 43(8-9):S125-32. PubMed ID: 6542777
    [No Abstract]   [Full Text] [Related]  

  • 10. New approach to management of chronic vascular rejection with prostacyclin analogue after kidney transplantation.
    Teraoka S; Takahashi K; Toma H; Yagisawa T; Yamaguchi Y; Sanaka T; Fuchinoue S; Honda H; Kawai T; Tanabe K
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2115-9. PubMed ID: 3547915
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S
    Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
    Okamoto S; Yonekawa Y; Handa H; Handa Y; Uemura Y; Yano I; Toyoshima M; Iwatsuji K; Teraura T; Yamagata S
    Nihon Geka Hokan; 1986 Jan; 55(1):251-9. PubMed ID: 3741043
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S; Akama H; Kume K; Higuchi E; Kamiyama S; Suzuki J; Ohara N; Yugeta E; Kato K; Suzuki H
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):341-6. PubMed ID: 3230687
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit.
    Chan RC; Durity FA; Thompson GB; Nugent RA; Kendall M
    J Neurosurg; 1984 Dec; 61(6):1120-8. PubMed ID: 6389786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of thromboxane A2 synthetase inhibitor on chronic rejection of kidney transplantation].
    Imanishi M; Ikegami M; Nishioka T; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1990 Jun; 81(6):895-901. PubMed ID: 2402113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A double-blind placebo-controlled study of OKY-046 in the treatment of chronic asthma].
    Kabe J
    Nihon Naika Gakkai Zasshi; 1989 Sep; 78(9):1288-92. PubMed ID: 2687415
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical study on effect of thromboxane A2 synthetase inhibitor (OKY-046) to clarify the regulation of cerebral blood flow in cerebral thrombosis.
    Nihei C; Metoki H; Shimanaka Y; Kawahara R; Komatsu O; Oike Y; Kanazawa T; Izawa M; Kaneko H; Hoshi Y
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():953-7. PubMed ID: 2960210
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y; Handa H; Okamoto S; Ohta T; Kamijo Y; Oda Y; Kondo A; Nin K; Yamamoto T; Ban S
    Nihon Geka Hokan; 1986 May; 55(3):473-84. PubMed ID: 3541826
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prostaglandin I2 analogue and thromboxane A2 synthetase inhibitor on chronic rejection in rats.
    Hirano T; Nakafusa Y; Nishinaka H; Takeda K; Kawano R; Nakano M; Arima T; Motoyama K; Nakamura K; Torada N; Ikematsu H; Kamei T; Tanaka M
    Transplant Proc; 1997; 29(1-2):1520. PubMed ID: 9123408
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic thromboxane inhibition preserves function of rejecting rat renal allografts.
    Coffman TM; Ruiz P; Sanfilippo F; Klotman PE
    Kidney Int; 1989 Jan; 35(1):24-30. PubMed ID: 2651752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.